OTCMKTS:ESALY

Eisai (ESALY) Stock Price, News & Analysis

Eisai logo
$61.51 -1.33 (-2.11%)
As of 01/30/2023

About Eisai Stock (OTCMKTS:ESALY)

Key Stats

Today's Range
$61.00
▼
$63.29
50-Day Range
$61.51
▼
$61.51
52-Week Range
$36.88
▼
$73.90
Volume
331,800 shs
Average Volume
60,916 shs
Market Capitalization
$17.64 billion
P/E Ratio
70.70
Dividend Yield
1.43%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Eisai is a Japan-based pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its research and commercial activities focus primarily on neurology and oncology, alongside other therapeutic areas.

The company’s medicines include lecanemab, marketed as Leqembi for Alzheimer’s disease in certain markets, and lenvatinib, marketed as Lenvima for several types of cancer. Eisai also offers treatments for conditions including insomnia, epilepsy and cancer.

Founded in Japan in 1941, Eisai serves patients and healthcare providers in Japan and other markets around the world. The company describes its approach to research and business as centered on addressing patients’ and their families’ needs.

AI Generated. May Contain Errors.

Receive ESALY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESALY Stock News Headlines

Eisai Co Ltd H1 Profit Climbs
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
See More Headlines

ESALY Stock Analysis - Frequently Asked Questions

Eisai's stock was trading at $61.51 at the beginning of 2026. Since then, ESALY shares have increased by 0.0% and is now trading at $61.51.

Eisai Co., Ltd. (OTCMKTS:ESALY) issued its earnings results on Wednesday, August, 4th. The company reported $1.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.09 by $0.25. The business had revenue of $1.82 billion for the quarter. Eisai had a trailing twelve-month return on equity of 3.86% and a net margin of 4.11%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eisai investors own include Intellia Therapeutics (NTLA), Impinj (PI), Trade Desk (TTD), Alibaba Group (BABA), Bristol Myers Squibb (BMY), Eli Lilly and Company (LLY) and Teladoc Health (TDOC).

Company Calendar

Today
11/18/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ESALY
CIK
948406
Employees
11,322
Year Founded
1941

Profitability

EPS (Trailing Twelve Months)
$0.87
Trailing P/E Ratio
70.70
Forward P/E Ratio
51.69
P/E Growth
2.46
Net Income
$426.79 million
Net Margins
4.11%
Pretax Margin
N/A
Return on Equity
3.86%
Return on Assets
2.50%

Debt

Debt-to-Equity Ratio
0.10
Current Ratio
2.20
Quick Ratio
1.77

Sales & Book Value

Annual Sales
$6.74 billion
Price / Sales
2.62
Cash Flow
$2.68 per share
Price / Cash Flow
22.94
Book Value
$23.94 per share
Price / Book
2.57

Miscellaneous

Outstanding Shares
286,770,000
Free Float
N/A
Market Cap
$17.64 billion
Optionable
Not Optionable
Beta
0.31

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:ESALY) was last updated on 1/30/2023 by MarketBeat.com Staff.
From Our Partners